Quick Read
Rocket Lab (RKLB) grew revenue 62% with a $2.36B backlog; AST SpaceMobile (ASTS) missed estimates and absorbed a $126M launch incident charge.
Peter Beck’s Iridium acquisition adds $870M in annual revenue, positioning Rocket Lab as a diversified compounder against AST’s all-in direct-to-phone broadband bet.
Neutron’s maiden flight and AST’s beta-to-paid conversion are the decisive catalysts, with both stocks down roughly 20% over the past month.
Just released. Our analysts combed the entire stock market and named the ten best stocks to buy right now, and Rocket Lab didn’t make the cut. Enter your email to see the names that beat RKLB. The report is free. Enter your email and see if any of your stocks made the cut.
Rocket Lab (NASDAQ:RKLB) and AST SpaceMobile (NASDAQ:ASTS) both reported Q2 2026 results on August 10, 2026. One is a vertically integrated launcher chasing SpaceX on rockets and satellites. The other is trying to be SpaceX for your phone. Same night, same “disruptor” label, radically different businesses.
Shutterstock Record Backlog for Rocket Lab, Beta Countdown for AST
Rocket Lab posted $234.07 million in revenue, up 62.0% year over year, with Space Systems contributing $189.5 million after the Mynaric and Motiv deals closed. Backlog swelled to $2.36 billion, up 137%, with launch capacity described as unusually constrained. CEO Peter Beck called it “another fantastic quarter”, and the numbers back him up.
AST SpaceMobile is earlier in its arc. Revenue reached $31.52 million, missing consensus by 8.36%, and the GAAP loss ballooned to -$0.77 per share after a $125.9 million charge tied to the BB7 launch incident. Still, the constellation now holds 13 spacecraft with roughly 20,000 square feet of aperture, and CEO Abel Avellan says the company is “preparing to initiate beta services with select strategic partners.”
Free Report, Just Released
Why Didn’t RKLB Make The Top 10 List?
24/7 Wall St has helped investors make money for over two decades, and our top analysts just finished ranking the definitive Top 10 Stocks To Buy Now. Not the ten biggest companies. Not the ten everyone is arguing about. The ten best stocks to buy right now.
And RKLB didn’t make the cut!
The report is free, and you can see why we think each stock is a top investment today.
Enter Your Email and See the Ten →
Business Driver
Rocket Lab
AST SpaceMobile
Main Revenue Engine
Satellite manufacturing and launch
Gateway hardware, government milestones
Backlog
$2.36B
~$1.30B
Cash on Hand
$2.13B
>$3.7B pro forma
Story Continues
Vertical Integration Versus a Single Bold Bet
Rocket Lab is stitching together a full space stack. The announced Iridium acquisition adds 66 satellites, 2.5 million subscribers, and more than $870 million in annual revenue. Neutron, priced at a $50 to $55 million ASP, is targeting a Q4 2026 pad delivery, with Beck admitting “the window for an end-of-year launch is narrowing.”
AST is doing one thing, at enormous scale: direct-to-smartphone broadband. It has 60-plus MNO partners covering 3 billion subscribers, a preliminary $1 billion J-LEO award with Rakuten in Japan, and Block 2 satellites aimed at ~200 Mbps peak data rates. Q2 capex hit roughly $610 million, so the runway matters.
Neutron Flight and Beta Launch Are the Real Catalysts
For Rocket Lab, I want to see Neutron actually leave the pad and Iridium close cleanly by mid-2027. For AST, the tell is beta service converting into paid commercial revenue and BlueBirds 17-46 launching on cadence toward ~45 satellites by early 2027. Both stocks have cooled, with RKLB down 22.56% over the past month and ASTS off 16.36%. The bar is higher now.
Why I Lean Toward Rocket Lab for Diversified Exposure
On the current data, Rocket Lab looks like the more diversified profile. Revenue is real, defense demand is stacking up (see the $397M Flatellite award), and the Iridium deal gives it a services annuity. AST is the higher-variance bet. If beta works and Japan converts, the upside is enormous. If launches slip again, dilution risk stays real. The framing splits cleanly: Rocket Lab as the compounder, AST as the moonshot (we wrote a free playbook on sizing speculative bets like this one without wrecking the rest of the portfolio, here). A bad Neutron test firing would raise the bar further on either name.
Got $1,000? Before You Buy RKLB, Read This
If you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And RKLB wasn’t one of them.
They combed the entire market. It’s not 10 ideas, not 10 stocks everyone is talking about, it’s what their research points to as the 10 best stocks to buy right now, and it’s free. Read more here and see which stocks made the list –>>
Contact editorial@247wallst.com for any questions or corrections.